Takeda Pharmaceutical (TAK) Acquisitions (2018 - 2021)

Takeda Pharmaceutical's Acquisitions history runs 4 years deep, the most recent figure standing at -$194.6 million for Q4 2021.

• In Q4 2021, Acquisitions changed N/A year-over-year to -$194.6 million; the TTM figure through Mar 2022 stood at -$446.3 million (changed N/A YoY), while the FY2022 annual figure was -$442.4 million, changed N/A from the prior year.
• Acquisitions was -$194.6 million for Q4 2021 at Takeda Pharmaceutical, up from -$251.7 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $652350.4 in Q3 2019 to a low of -$26.3 billion in Q1 2019.
• Historically, Acquisitions has averaged -$3.4 billion across 4 years, with a median of -$127.7 million in 2021.
• Biggest YoY gain for Acquisitions was 101.07% in 2019; the steepest drop was 92.31% in 2019.
• A 4-year view of Acquisitions shows it stood at -$60.9 million in 2018, then jumped by 101.07% to $652350.4 in 2019, then slumped by 522.37% to -$2.8 million in 2020, then plunged by 6963.45% to -$194.6 million in 2021.
• The last three Acquisitions figures came in at -$194.6 million (Q4 2021), -$251.7 million (Q2 2021), and -$2.8 million (Q1 2020), per Business Quant data.